Plus Therapeutics, Inc

PSTVNASDAQ · Surgical & Medical Instruments & Apparatus

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

7.31M

on 2026-06-30, from 171K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-25 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$100.0M

S-3 of 2026-06-02. None sold under it to 2026-10-05. S-3 ↗

$17.4M

Canaccord Genuity, agreement of 2026-06-05. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

1.82M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

1.5 quarters

$8.6M on 2026-06-30 ÷ $5.5M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-09-04	Private placement	not read	not read	$3.0M	8-K ↗
2026-01-14	Public offering	39,473,684	$0.38	$15.0M	424B4 ↗

Also on file: a 1-for-25 reverse split, 2026-04-01 8-K ↗